| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |